Gujarat Themis Biosyn Share Price

NSE
333.15
-12.90 (3.83%)
GUJTHEM • 13 Jun, 2025 | 03:29 PM
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Gujarat Themis Biosyn Stock Performance
Today’s Low - High
332.35
343.75
332.35
343.75
52 Week Low - High
208.00
354.50
208.00
354.50

Open

335.00

Prev. Close

346.05

Total Traded Value

2.82 Cr

View details of Market Depth
Gujarat Themis Biosyn Fundamental

Market Cap (in crs)

3,645.98

Face Value

1

Turnover (in lacs)

281.53

Key Metrics
Qtr Change %
73.51% Gain from 52W Low
35.6
Dividend yield 1yr %
Low in industry
0.05

Gujarat Themis Biosyn shareholding Pattern

Promoter
70.9%
Foreign Institutions
1.9%
Mutual Funds
1.2%
Domestic Institutions
1.2%
Public
26%
Promoter
70.9%
Foreign Institutions
1.4%
Mutual Funds
1.2%
Domestic Institutions
1.2%
Public
26.6%
Promoter
70.9%
Foreign Institutions
1.5%
Mutual Funds
1.2%
Domestic Institutions
1.2%
Public
26.5%
Promoter
70.9%
Foreign Institutions
1.4%
Mutual Funds
1.2%
Domestic Institutions
1.2%
Public
26.5%
Promoter
70.9%
Foreign Institutions
1%
Mutual Funds
0.8%
Domestic Institutions
0.9%
Public
27.3%
Promoter
70.9%
Foreign Institutions
0.9%
Public
28.2%

Gujarat Themis Biosyn Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
333.15
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
339.00
10Day EMA
333.40
12Day EMA
331.20
20Day EMA
323.80
26Day EMA
319.10
50Day EMA
306.40
100Day EMA
298.90
200Day EMA
293.80
5Day SMA
343.60
10Day SMA
331.90
20Day SMA
322.40
30Day SMA
312.80
50Day SMA
299.80
100Day SMA
285.60
150Day SMA
297.30
200Day SMA
307.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
47307 Rs
98043 Rs
Week Rs
253897 Rs
396084 Rs
Month Rs
163769 Rs
288041 Rs
Resistance & Support
336.12
Pivot
Resistance
First Resistance
341.13
Second Resistance
348.52
Third Resistance
353.53
Support
First Support
328.73
Second support
323.72
Third Support
316.33
Relative Strength Index
56.79
Money Flow Index
60.82
MACD
12.13
MACD Signal
10.59
Average True Range
17.06
Average Directional Index
15.09
Rate of Change (21)
2.55
Rate of Change (125)
2.22
Shareholding
Name
Holding Percent
Quant Mutual Fund - Quant Manufacturing Fund
1.15

Gujarat Themis Biosyn Latest News

13 JUN 2025 | Friday

Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Change in Management

13 JUN 2025 | Friday

Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Regulation 30 Of SEBI (LODR)- Withdrawal Of Scheme Of Amalgamation.

13 JUN 2025 | Friday

Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th June, 2025

View More

Gujarat Themis Biosyn Company background

Founded in: 1981
Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG) a unique consortium of five competing drug companies Themis Medicare Ltd., Kopran Ltd., Anant Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL.During 199596 the paidup share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year 201920, installed capacity of rifamysinS was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of antituberculosis products and other antibiotics in 2022.The Company is presently in the business of manufacturing and sale of raw material by fermentation process.

As of 13 Jun, 2025, GUJTHEM share price is ₹333.8. The stock opened at ₹331.1 and had closed at ₹346.6 the previous day. During today’s trading session, GUJTHEM share price moved between ₹332.35 and ₹343.75, with an average price for the day of ₹337.50. Over the last 52 weeks, the stock has recorded a low of ₹208.00 and a high of ₹354.50. In terms of performance, GUJTHEM share price has increased by 2.6% over the past six months and has increased by 42.14% over the last year.

Read More

Gujarat Themis Biosyn FAQs

Gujarat Themis Biosyn share price is ₹333.15 in NSE and ₹333 in BSE as on 13/6/2025.

Gujarat Themis Biosyn share price in the past 1-year return was 34394.84. The Gujarat Themis Biosyn share hit a 1-year low of Rs. 208 and a 1-year high of Rs. 354.5.

The market cap of Gujarat Themis Biosyn is Rs. 3645.98 Cr. as of 13/6/2025.

The PE ratios of Gujarat Themis Biosyn is 74.5 as of 13/6/2025.

The PB ratios of Gujarat Themis Biosyn is 14.64 as of 13/6/2025

The Mutual Fund Shareholding in Gujarat Themis Biosyn was 1.16% at the end of 13/6/2025.

You can easily buy Gujarat Themis Biosyn shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Gujarat Themis Biosyn stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -